4//SEC Filing
Litton Mark James 4
Accession 0001415889-24-004166
CIK 0001620463other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:05 PM ET
Size
5.6 KB
Accession
0001415889-24-004166
Insider Transaction Report
Form 4
Litton Mark James
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-15+650,000→ 650,000 totalExercise: $3.66Exp: 2034-02-14→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]Shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001604834
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:05 PM ET
- Size
- 5.6 KB